BRITTANY DUPREE: Open Payments
NPI 1902382997 · SNELLVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,106 in 121 payments from 19 companies in 2025. Trend: 2023 $3,966 · 2024 $2,480 · 2025 $2,106
Food & beverage: $2,087Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $612 |
| Novartis Pharmaceuticals Corporation | 16 | $417 |
| PFIZER INC. | 11 | $177 |
| UCB, Inc. | 20 | $171 |
| GENZYME CORPORATION | 4 | $148 |
| Galderma Laboratories, L.P. | 9 | $148 |
| Janssen Biotech, Inc. | 3 | $70 |
| Organon LLC | 5 | $57 |
| Janssen Scientific Affairs, LLC | 1 | $46 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
Products named: SKYRIZI, RINVOQ, COSENTYX, CIBINQO, Bimzelx, DUPIXENT, NEMLUVIO, TREMFYA.
Industry payments across GA — which companies pay providers there.
